CLDX – Celldex Therapeutics, Inc.
CLDX — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
9.97
Margin Of Safety %
Put/Call OI Ratio
1.29
EPS Next Q Diff
EPS Last/This Y
-0.84
EPS This/Next Y
-0.06
Price
32
Target Price
57.29
Analyst Recom
1.2
Performance Q
29.92
Upside
-273.5%
Beta
0.97
Ticker: CLDX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-04-13 | CLDX | 32.57 | 1.04 | 0.81 | 4227 |
| 2026-04-14 | CLDX | 33.32 | 1.03 | 0.22 | 4270 |
| 2026-04-15 | CLDX | 33.86 | 1.03 | 0.07 | 4301 |
| 2026-04-17 | CLDX | 34.51 | 1.01 | 0.07 | 4377 |
| 2026-04-20 | CLDX | 34.36 | 0.87 | 0.51 | 3728 |
| 2026-04-21 | CLDX | 34.24 | 0.87 | 0.38 | 3774 |
| 2026-04-23 | CLDX | 33.58 | 0.78 | 0.00 | 4314 |
| 2026-04-24 | CLDX | 33.29 | 0.77 | 0.15 | 4344 |
| 2026-04-27 | CLDX | 33.65 | 0.77 | 0.02 | 4366 |
| 2026-04-28 | CLDX | 33.25 | 0.71 | 68.82 | 4576 |
| 2026-04-29 | CLDX | 32.12 | 1.27 | 0.78 | 6110 |
| 2026-04-30 | CLDX | 32.87 | 1.27 | 0.00 | 6122 |
| 2026-05-01 | CLDX | 32.3 | 1.27 | 0.00 | 6121 |
| 2026-05-04 | CLDX | 32.73 | 1.25 | 0.50 | 6151 |
| 2026-05-05 | CLDX | 33.85 | 1.25 | 0.63 | 6157 |
| 2026-05-06 | CLDX | 34.36 | 1.25 | 0.13 | 6183 |
| 2026-05-07 | CLDX | 32.02 | 1.24 | 1.25 | 6217 |
| 2026-05-08 | CLDX | 33.93 | 1.23 | 0.00 | 6236 |
| 2026-05-11 | CLDX | 32.33 | 1.24 | 5.73 | 6219 |
| 2026-05-12 | CLDX | 31.98 | 1.29 | 0.04 | 6381 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-04-13 | CLDX | 32.58 | -39.8 | -94.3 | -4.73 |
| 2026-04-14 | CLDX | 33.33 | -39.8 | -100.3 | -4.73 |
| 2026-04-15 | CLDX | 33.83 | -39.8 | -96.5 | -4.73 |
| 2026-04-16 | CLDX | 33.86 | -39.8 | -89.2 | -4.73 |
| 2026-04-17 | CLDX | 34.51 | -39.8 | -98.3 | -4.73 |
| 2026-04-20 | CLDX | 34.38 | -39.8 | -87.6 | -4.73 |
| 2026-04-21 | CLDX | 34.25 | -39.8 | -87.6 | -4.80 |
| 2026-04-22 | CLDX | 34.22 | -39.8 | -89.0 | -4.80 |
| 2026-04-23 | CLDX | 33.56 | -39.8 | -80.7 | -4.80 |
| 2026-04-24 | CLDX | 33.29 | -39.8 | -85.7 | -4.80 |
| 2026-04-27 | CLDX | 33.65 | -39.8 | -94.6 | -4.73 |
| 2026-04-28 | CLDX | 33.23 | -39.8 | -83.5 | -4.73 |
| 2026-04-30 | CLDX | 32.87 | -39.8 | -100.1 | -4.73 |
| 2026-05-01 | CLDX | 32.30 | -39.8 | -81.1 | -4.73 |
| 2026-05-04 | CLDX | 32.75 | -39.8 | -96.0 | -4.73 |
| 2026-05-05 | CLDX | 33.85 | -39.8 | -105.2 | -4.73 |
| 2026-05-06 | CLDX | 34.36 | -39.8 | -96.5 | -4.73 |
| 2026-05-07 | CLDX | 33.33 | -39.8 | -75.0 | -4.73 |
| 2026-05-08 | CLDX | 33.96 | -39.8 | -98.6 | -4.73 |
| 2026-05-11 | CLDX | 32.30 | -41.6 | -46.1 | -4.74 |
| 2026-05-12 | CLDX | 32.00 | -25.2 | -63.6 | -4.74 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-04-13 | CLDX | -2.37 | 3.86 | 14.04 |
| 2026-04-14 | CLDX | -2.37 | 3.86 | 14.04 |
| 2026-04-15 | CLDX | -2.33 | 3.86 | 11.91 |
| 2026-04-16 | CLDX | -2.33 | 3.86 | 11.91 |
| 2026-04-17 | CLDX | -2.33 | 3.86 | 11.91 |
| 2026-04-20 | CLDX | -2.33 | 3.85 | 11.91 |
| 2026-04-21 | CLDX | -2.33 | 3.85 | 11.91 |
| 2026-04-22 | CLDX | -2.33 | 3.85 | 11.91 |
| 2026-04-23 | CLDX | -2.33 | 3.85 | 11.91 |
| 2026-04-24 | CLDX | -2.33 | 3.85 | 11.91 |
| 2026-04-27 | CLDX | -2.33 | 4.22 | 10.90 |
| 2026-04-28 | CLDX | -2.33 | 4.22 | 10.90 |
| 2026-04-29 | CLDX | -2.33 | 4.22 | 10.90 |
| 2026-04-30 | CLDX | -2.33 | 4.22 | 10.90 |
| 2026-05-01 | CLDX | -2.33 | 4.22 | 10.90 |
| 2026-05-04 | CLDX | -2.33 | 4.07 | 10.90 |
| 2026-05-05 | CLDX | -2.33 | 4.07 | 10.90 |
| 2026-05-06 | CLDX | -2.33 | 4.07 | 10.90 |
| 2026-05-07 | CLDX | -2.33 | 4.07 | 10.90 |
| 2026-05-08 | CLDX | -2.33 | 4.07 | 10.90 |
| 2026-05-11 | CLDX | -2.33 | 3.03 | 10.90 |
| 2026-05-12 | CLDX | -2.33 | 3.03 | 9.97 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-1.13
Avg. EPS Est. Next Quarter
-0.92
Insider Transactions
-2.33
Institutional Transactions
3.03
Beta
0.97
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
19
Growth Score
29
Sentiment Score
67
Actual DrawDown %
44.1
Max Drawdown 5-Year %
-73.1
Target Price
57.29
P/E
Forward P/E
PEG
P/S
2887.06
P/B
4.67
P/Free Cash Flow
EPS
-4.27
Average EPS Est. Cur. Y
-4.74
EPS Next Y. (Est.)
-4.8
Target Price Estimates Raised
1
Target Price Estimates Lowered
Profit Margin
-32753.58
Relative Volume
0.73
Return on Equity vs Sector %
-89
Return on Equity vs Industry %
-73.5
EPS 1 7Days Diff
EPS 1 30Days Diff
0.03
EBIT Estimation
-63.6
◆
CLDX
Healthcare
$32.00
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
46
Range 1M
6.3%
Sup Dist
2.8%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-11.5%
EPS NY
-1.2%
52W%
77.6%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+79% upside
Upside
+79%
Quality
19
Celldex Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 198
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. Celldex Therapeutics, Inc. is headquartered in Hampton, New Jersey.
CLDX
Latest News
—
Caricamento notizie per CLDX…
stock quote shares CLDX – Celldex Therapeutics, Inc. Stock Price stock today
news today CLDX – Celldex Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CLDX – Celldex Therapeutics, Inc. yahoo finance google finance
stock history CLDX – Celldex Therapeutics, Inc. invest stock market
stock prices CLDX premarket after hours
ticker CLDX fair value insiders trading